APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prescription Weight Loss Pills

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prescription Weight Loss Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174028330322 December 2025199 pages

Choose your research edition.

Industry ResearchPrescription Weight Loss Pills Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Weight Loss Pills Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Prescription Weight Loss Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Weight Loss Pills Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Weight Loss Pills Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Weight Loss Pills market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Weight Loss Pills include Teva Pharmaceutical (Actavis), Sanofi (Adlyxin), Novo Nordisk A/S, Eli Lilly and Company (TRICARE), Pfizer, AstraZeneca (BYDUREON BCise), VIVUS (Qsymia), Rhythm Pharmaceuticals (Imcivree) and Haleon Group (alli), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prescription Weight Loss Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prescription Weight Loss Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prescription Weight Loss Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prescription Weight Loss Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Prescription Weight Loss Pills Segment by Company

Teva Pharmaceutical (Actavis)

Sanofi (Adlyxin)

Novo Nordisk A/S

Eli Lilly and Company (TRICARE)

Pfizer

AstraZeneca (BYDUREON BCise)

VIVUS (Qsymia)

Rhythm Pharmaceuticals (Imcivree)

Haleon Group (alli)

Currax Pharmaceuticals (Contrave)

CHEPLAPHARM (Xenical)

Prescription Weight Loss Pills Segment by Type

Injections

Oral Tablets

Oral Capsules

Prescription Weight Loss Pills Segment by Application

Hospital

Pharmacy

Prescription Weight Loss Pills Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Weight Loss Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Weight Loss Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Weight Loss Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prescription Weight Loss Pills market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prescription Weight Loss Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prescription Weight Loss Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prescription Weight Loss Pills Industry Trends Table 2. Prescription Weight Loss Pills Industry Drivers Table 3. Prescription Weight Loss Pills Industry Opportunities and Challenges Table 4. Prescription Weight Loss Pills Industry Restraints Table 5. Global Prescription Weight Loss Pills Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prescription Weight Loss Pills Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prescription Weight Loss Pills Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Prescription Weight Loss Pills Sales Market Share by Manufacturers Table 9. Global Prescription Weight Loss Pills Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Prescription Weight Loss Pills Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prescription Weight Loss Pills Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prescription Weight Loss Pills Manufacturers, Product Type & Application Table 13. Global Prescription Weight Loss Pills Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prescription Weight Loss Pills by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injections Table 17. Major Manufacturers of Oral Tablets Table 18. Major Manufacturers of Oral Capsules Table 19. Global Prescription Weight Loss Pills Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Prescription Weight Loss Pills Sales by Type (2021-2026) & (k units) Table 21. Global Prescription Weight Loss Pills Sales by Type (2027-2032) & (k units) Table 22. Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2026) Table 23. Global Prescription Weight Loss Pills Sales Market Share by Type (2027-2032) Table 24. Global Prescription Weight Loss Pills Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Prescription Weight Loss Pills Revenue by Type (2021-2026) & (k units) Table 26. Global Prescription Weight Loss Pills Revenue by Type (2027-2032) & (k units) Table 27. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2026) Table 28. Global Prescription Weight Loss Pills Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Pharmacy Table 31. Global Prescription Weight Loss Pills Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Prescription Weight Loss Pills Sales by Application (2021-2026) & (k units) Table 33. Global Prescription Weight Loss Pills Sales by Application (2027-2032) & (k units) Table 34. Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2026) Table 35. Global Prescription Weight Loss Pills Sales Market Share by Application (2027-2032) Table 36. Global Prescription Weight Loss Pills Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Prescription Weight Loss Pills Revenue by Application (2021-2026) & (k units) Table 38. Global Prescription Weight Loss Pills Revenue by Application (2027-2032) & (k units) Table 39. Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2026) Table 40. Global Prescription Weight Loss Pills Revenue Market Share by Application (2027-2032) Table 41. Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Prescription Weight Loss Pills Sales by Region (2021-2026) & (k units) Table 43. Global Prescription Weight Loss Pills Sales Market Share by Region (2021-2026) Table 44. Global Prescription Weight Loss Pills Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Prescription Weight Loss Pills Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 48. North America Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 49. Europe Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 51. Europe Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Prescription Weight Loss Pills Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Prescription Weight Loss Pills Sales by Country (2027-2032) & (k units) Table 58. Global Prescription Weight Loss Pills Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Prescription Weight Loss Pills Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Prescription Weight Loss Pills Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Prescription Weight Loss Pills Revenue Market Share by Region (2021-2026) Table 62. Global Prescription Weight Loss Pills Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical (Actavis) Company Information Table 64. Teva Pharmaceutical (Actavis) Business Overview Table 65. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio Table 67. Teva Pharmaceutical (Actavis) Recent Development Table 68. Sanofi (Adlyxin) Company Information Table 69. Sanofi (Adlyxin) Business Overview Table 70. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio Table 72. Sanofi (Adlyxin) Recent Development Table 73. Novo Nordisk A/S Company Information Table 74. Novo Nordisk A/S Business Overview Table 75. Novo Nordisk A/S Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio Table 77. Novo Nordisk A/S Recent Development Table 78. Eli Lilly and Company (TRICARE) Company Information Table 79. Eli Lilly and Company (TRICARE) Business Overview Table 80. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio Table 82. Eli Lilly and Company (TRICARE) Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Prescription Weight Loss Pills Product Portfolio Table 87. Pfizer Recent Development Table 88. AstraZeneca (BYDUREON BCise) Company Information Table 89. AstraZeneca (BYDUREON BCise) Business Overview Table 90. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio Table 92. AstraZeneca (BYDUREON BCise) Recent Development Table 93. VIVUS (Qsymia) Company Information Table 94. VIVUS (Qsymia) Business Overview Table 95. VIVUS (Qsymia) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio Table 97. VIVUS (Qsymia) Recent Development Table 98. Rhythm Pharmaceuticals (Imcivree) Company Information Table 99. Rhythm Pharmaceuticals (Imcivree) Business Overview Table 100. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio Table 102. Rhythm Pharmaceuticals (Imcivree) Recent Development Table 103. Haleon Group (alli) Company Information Table 104. Haleon Group (alli) Business Overview Table 105. Haleon Group (alli) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio Table 107. Haleon Group (alli) Recent Development Table 108. Currax Pharmaceuticals (Contrave) Company Information Table 109. Currax Pharmaceuticals (Contrave) Business Overview Table 110. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio Table 112. Currax Pharmaceuticals (Contrave) Recent Development Table 113. CHEPLAPHARM (Xenical) Company Information Table 114. CHEPLAPHARM (Xenical) Business Overview Table 115. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio Table 117. CHEPLAPHARM (Xenical) Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Prescription Weight Loss Pills Distributors List Table 121. Prescription Weight Loss Pills Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Prescription Weight Loss Pills Product Image Figure 2. Global Prescription Weight Loss Pills Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Weight Loss Pills Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Weight Loss Pills Sales (2021-2032) & (k units) Figure 5. Global Prescription Weight Loss Pills Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prescription Weight Loss Pills Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injections Image Figure 9. Oral Tablets Image Figure 10. Oral Capsules Image Figure 11. Global Prescription Weight Loss Pills Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Prescription Weight Loss Pills Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2032) Figure 14. Global Prescription Weight Loss Pills Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Prescription Weight Loss Pills Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Global Prescription Weight Loss Pills Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Prescription Weight Loss Pills Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2032) Figure 22. Global Prescription Weight Loss Pills Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Prescription Weight Loss Pills Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2032) Figure 25. North America Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Prescription Weight Loss Pills Sales Market Share by Country (2021-2032) Figure 27. U.S. Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Prescription Weight Loss Pills Sales Market Share by Country (2021-2032) Figure 32. Germany Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Prescription Weight Loss Pills Sales Market Share by Country (2021-2032) Figure 39. China Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Prescription Weight Loss Pills Sales Market Share by Country (2021-2032) Figure 47. Brazil Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Prescription Weight Loss Pills Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Prescription Weight Loss Pills Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Prescription Weight Loss Pills Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Figure 58. North America Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Figure 60. Europe Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Prescription Weight Loss Pills Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prescription Weight Loss Pills Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Prescription Weight Loss Pills Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Oral Tablets
  • Oral Capsules
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Teva Pharmaceutical (Actavis)
  • Sanofi (Adlyxin)
  • Novo Nordisk A/S
  • Eli Lilly and Company (TRICARE)
  • Pfizer
  • AstraZeneca (BYDUREON BCise)
  • VIVUS (Qsymia)
  • Rhythm Pharmaceuticals (Imcivree)
  • Haleon Group (alli)
  • Currax Pharmaceuticals (Contrave)
  • CHEPLAPHARM (Xenical)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prescription Weight Loss Pills Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prescription Weight Loss Pills Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prescription Weight Loss Pills Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prescription Weight Loss Pills Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prescription Weight Loss Pills Market Dynamics
  1. 2.1 Prescription Weight Loss Pills Industry Trends
  2. 2.2 Prescription Weight Loss Pills Industry Drivers
  3. 2.3 Prescription Weight Loss Pills Industry Opportunities and Challenges
  4. 2.4 Prescription Weight Loss Pills Industry Restraints
3 Prescription Weight Loss Pills Market by Manufacturers
  1. 3.1 Global Prescription Weight Loss Pills Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prescription Weight Loss Pills Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prescription Weight Loss Pills Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prescription Weight Loss Pills Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Weight Loss Pills Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prescription Weight Loss Pills Manufacturers, Product Type & Application
  7. 3.7 Global Prescription Weight Loss Pills Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Weight Loss Pills Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Weight Loss Pills Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Weight Loss Pills Tier 1, Tier 2, and Tier 3
4 Prescription Weight Loss Pills Market by Type
  1. 4.1 Prescription Weight Loss Pills Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Oral Tablets
  4. 4.1.3 Oral Capsules
  5. 4.2 Global Prescription Weight Loss Pills Sales by Type
  6. 4.2.1 Global Prescription Weight Loss Pills Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prescription Weight Loss Pills Sales by Type (2021-2032)
  8. 4.2.3 Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2032)
  9. 4.3 Global Prescription Weight Loss Pills Revenue by Type
  10. 4.3.1 Global Prescription Weight Loss Pills Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Prescription Weight Loss Pills Revenue by Type (2021-2032)
  12. 4.3.3 Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2032)
5 Prescription Weight Loss Pills Market by Application
  1. 5.1 Prescription Weight Loss Pills Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Prescription Weight Loss Pills Sales by Application
  5. 5.2.1 Global Prescription Weight Loss Pills Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prescription Weight Loss Pills Sales by Application (2021-2032)
  7. 5.2.3 Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2032)
  8. 5.3 Global Prescription Weight Loss Pills Revenue by Application
  9. 5.3.1 Global Prescription Weight Loss Pills Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Prescription Weight Loss Pills Revenue by Application (2021-2032)
  11. 5.3.3 Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2032)
6 Global Prescription Weight Loss Pills Sales by Region
  1. 6.1 Global Prescription Weight Loss Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prescription Weight Loss Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Prescription Weight Loss Pills Sales by Region (2021-2026)
  4. 6.2.2 Global Prescription Weight Loss Pills Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prescription Weight Loss Pills Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prescription Weight Loss Pills Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prescription Weight Loss Pills Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prescription Weight Loss Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prescription Weight Loss Pills Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prescription Weight Loss Pills Revenue by Region
  1. 7.1 Global Prescription Weight Loss Pills Revenue by Region
  2. 7.1.1 Global Prescription Weight Loss Pills Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prescription Weight Loss Pills Revenue by Region (2021-2026)
  4. 7.1.3 Global Prescription Weight Loss Pills Revenue by Region (2027-2032)
  5. 7.1.4 Global Prescription Weight Loss Pills Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prescription Weight Loss Pills Revenue (2021-2032)
  8. 7.2.2 North America Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prescription Weight Loss Pills Revenue (2021-2032)
  11. 7.3.2 Europe Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prescription Weight Loss Pills Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prescription Weight Loss Pills Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prescription Weight Loss Pills Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical (Actavis)
  2. 8.1.1 Teva Pharmaceutical (Actavis) Company Information
  3. 8.1.2 Teva Pharmaceutical (Actavis) Business Overview
  4. 8.1.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
  6. 8.1.5 Teva Pharmaceutical (Actavis) Recent Developments
  7. 8.2 Sanofi (Adlyxin)
  8. 8.2.1 Sanofi (Adlyxin) Company Information
  9. 8.2.2 Sanofi (Adlyxin) Business Overview
  10. 8.2.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
  12. 8.2.5 Sanofi (Adlyxin) Recent Developments
  13. 8.3 Novo Nordisk A/S
  14. 8.3.1 Novo Nordisk A/S Company Information
  15. 8.3.2 Novo Nordisk A/S Business Overview
  16. 8.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
  18. 8.3.5 Novo Nordisk A/S Recent Developments
  19. 8.4 Eli Lilly and Company (TRICARE)
  20. 8.4.1 Eli Lilly and Company (TRICARE) Company Information
  21. 8.4.2 Eli Lilly and Company (TRICARE) Business Overview
  22. 8.4.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
  24. 8.4.5 Eli Lilly and Company (TRICARE) Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Prescription Weight Loss Pills Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 AstraZeneca (BYDUREON BCise)
  32. 8.6.1 AstraZeneca (BYDUREON BCise) Company Information
  33. 8.6.2 AstraZeneca (BYDUREON BCise) Business Overview
  34. 8.6.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
  36. 8.6.5 AstraZeneca (BYDUREON BCise) Recent Developments
  37. 8.7 VIVUS (Qsymia)
  38. 8.7.1 VIVUS (Qsymia) Company Information
  39. 8.7.2 VIVUS (Qsymia) Business Overview
  40. 8.7.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
  42. 8.7.5 VIVUS (Qsymia) Recent Developments
  43. 8.8 Rhythm Pharmaceuticals (Imcivree)
  44. 8.8.1 Rhythm Pharmaceuticals (Imcivree) Company Information
  45. 8.8.2 Rhythm Pharmaceuticals (Imcivree) Business Overview
  46. 8.8.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
  48. 8.8.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments
  49. 8.9 Haleon Group (alli)
  50. 8.9.1 Haleon Group (alli) Company Information
  51. 8.9.2 Haleon Group (alli) Business Overview
  52. 8.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
  54. 8.9.5 Haleon Group (alli) Recent Developments
  55. 8.10 Currax Pharmaceuticals (Contrave)
  56. 8.10.1 Currax Pharmaceuticals (Contrave) Company Information
  57. 8.10.2 Currax Pharmaceuticals (Contrave) Business Overview
  58. 8.10.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
  60. 8.10.5 Currax Pharmaceuticals (Contrave) Recent Developments
  61. 8.11 CHEPLAPHARM (Xenical)
  62. 8.11.1 CHEPLAPHARM (Xenical) Company Information
  63. 8.11.2 CHEPLAPHARM (Xenical) Business Overview
  64. 8.11.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
  66. 8.11.5 CHEPLAPHARM (Xenical) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prescription Weight Loss Pills Value Chain Analysis
  2. 9.1.1 Prescription Weight Loss Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prescription Weight Loss Pills Production Mode & Process
  6. 9.2 Prescription Weight Loss Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prescription Weight Loss Pills Distributors
  9. 9.2.3 Prescription Weight Loss Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst